Whole proteome analysis of LN18 cell treated with one of five DNA-damaging treatments (fractionated irradiation (IRM), temozolomide (TMZ), acute irradiation 24 hours (IRS 24h), acute irradiation 48 hours (IRS 48h) or doxorubicin (Dox)) +/- the BCL6 inhibitor FX1.
[doi:10.25345/C57W6796R]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: Glioblastoma ; BCL6 ; Irradiation ; Temozolomide ; Doxorubicin ; Whole proteome
|
Principal Investigators: (in alphabetical order) |
Melanie McConnell, VUW, New Zealand Paul Teesdale-Spittle, VUW, New Zealand |
| Submitting User: | tribean |
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | Browse Results |
|
FTP Download Link (click to copy):
|
|